Let's collaborate and create quality liposome encapsulated drugs together. Contact Us!
SyVento BioTech is a biotechnology company offering comprehensive services in the development of lipid-based nanocarriers and LNP technology. We specialize in the development of lipid-based formulations for pharmaceutical products, including RNA-based drug products.
Genetic platform
SyVento BioTech’s R&D Team offers technical and scientific support throughout the entire process, including advice on troubleshooting and optimization of RNA synthesis conditions. Our RNA synthesis proficiency guarantees successful results in downstream applications.
By incorporating these important features, our genetic platform for RNA synthesis
provides:
Delivery platform
Our Team’s qualifications and experience provide a wealth of expertise in the development of lipid-based delivery systems.
SyVento BioTech’s LNP delivery systems:
Manufacturing platform
Our capabilities offer the possibility of scaling the production of formulations based on lipid nanocarriers by transferring solutions developed in the laboratory on a semi-technical and technical scale.
Thanks to the extensive equipment base, we are able to perform:
Drug development expertise
November 7, 2025
Join us at International mRNA Health ConferenceWe are excited to announce that SyVento BioTech will be participating in the 13th mRNA Health Conference in Berlin! This annual event will take place on 11-13 November, bringing together leading experts in hasztag#mRNA science and we are proud to be part of this important dialogue. Our representatives, Dominik Lipka PhD Eng. – CTO, and […]
November 5, 2025
SyVento BioTech will be participating in TIDES!Join us next week at TIDES: Oligonucleotides and Peptide Therapeutics in Basel! SyVento BioTech will be represeted by Anna Michalska and Andreas Stocker who will be more than happy to discuss potential collaboration. We offer hasztag#CDMO services for preclinical and clinical drug development, GMP manufacturing and aseptic fill & finish. Our expertise includes mRNA/LNP technologies […]
October 27, 2025
Exciting weeks are ahead for SyVento BioTech!As October turns into November, exciting weeks are ahead for SyVento BioTech! While we are finalizing preparations for CPHI Milan (booth #3.1H80A) we are also eagerly looking forward to hasztag#BIOEurope, taking place 3–5 November in Vienna, Austria. BIO-Europe is one of the leading partnering conferences for the global biotech and pharmaceutical industry – where innovation, […]
October 3, 2025
Visit our booth at CPHI 2025!At the end of this month, the global pharma community will gather for CPHI Milan 2025 – and SyVento BioTech is looking forward to be part of it. We specialize in comprehensive hasztag#CDMO services for pharma and biotech innovatiors, offering preclinical/clinical drug development, RUO/GMP-grade mRNA synthesis, manufacturing of GMP commercial/clinical batches, and aseptic fill & […]
October 1, 2025
SyVento BioTech will join Nordic Life Science Days 2025 in GothenburgWe are glad to share that SyVento BioTech will join Nordic Life Science Days 2025 in Gothenburg on 13 – 14October. NLSDays is the key Nordic meeting point for biotech and pharma innovators – a place to exchange ideas, start conversations, and explore collaborations. You will find us at the Polish National Pavilion (PAIH) at […]
September 24, 2025
Strategic partnership with Kymos GroupWe are thrilled to announce a strategic partnership between SyVento BioTech and Kymos Group, aimed at unlocking the full potential of the CDMO and CRO services offered by both companies. By combining SyVento’s expertise in preclinical/clinical drug development, liposomal/LNP technologies and GMP manufacturing of clinical/ commercial batches with Kymos’ excellence in advanced bioanalytical and CMC […]
September 22, 2025
SyVento BioTech will be participating in The World Vaccine Congress in Amsterdam!We are delighted to share that SyVento BioTech will be participating in the upcoming The World Vaccine Congress in Amsterdam! At SyVento BioTech, we are committed to advancing the future of vaccines and novel therapies by offering integrated services – from mRNA synthesis and liposomal/LNP formulation development to cGMP manufacturing and beyond – all with […]
September 19, 2025
Panel discussion “mRNA Delivery Innovation” at the 2nd Annual Meeting of AMMWe were proud to see our CTO, Dominik Lipka PhD Eng. join the panel discussion “mRNA Delivery Innovation” at the 2nd Annual Meeting of AMM yesterday. Together with industry leaders from Cytiva, Cytonus Therapeutics, and Acuitas Therapeutics, the panel- moderated by Anna Rose Welch (Advancing RNA) – shared valuable insights on the future of delivery […]
September 16, 2025
SyVento BioTech will join Prague.bio ConferenceWe are delighted to announce that SyVento BioTech will join this year’s Prague.bio Conference, taking place on 25 September 2025 at the National House Vinohrady in Prague. Our company will be represented by Eliza Milewicz, who will be there to meet partners, exchange ideas and explore new opportunities in biotech innovation. Prague.bio is the leading […]
Let's collaborate and create quality liposome encapsulated drugs together.